Baku 27° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
15:01
Azerbaijan's economy grows by 1%
Finance14:57
Jeyhun Bayramov discusses peace process in South Caucasus with US State Department official
Foreign policy14:56
UAE president visits Doha in show of solidarity with Qatar
Other countries14:50
Polish expert: Russian drone incident may trigger NATO Article 4
Other countries14:47
Azerbaijan to host ITF's annual summit in May 2026
Infrastructure14:41
Natig Jafarov: Middle Corridor's potential outweighs its challenges
Infrastructure14:38
Katz: We'll hit our enemies anywhere
Other countries14:38
Azerbaijani parliament to discuss establishing embassy in Bahrain
Milli Majlis14:18
Photo